Skip to main content
Top
Published in: BMC Ophthalmology 1/2014

Open Access 01-12-2014 | Research article

Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan

Authors: Wen-Ling Liao, Lei Wan, Tzu-Yuan Wang, Ching-Chu Chen, Siu-San Tse, Chieh-Hsiang Lu, Fuu-Jen Tsai

Published in: BMC Ophthalmology | Issue 1/2014

Login to get access

Abstract

Background

Graves’ disease (GD) and Graves’ ophthalmopathy (GO) are autoimmune disorders, which might be influenced by genetic factors. Copy number variation (CNV) is an important source of genomic diversity in humans, and influences disease susceptibility. This study investigated the association between CNV in the TSHR and TLR7 genes and the development of GD and GO in a Chinese population in Taiwan.

Methods

For this case-control study, sample from 196 healthy controls and 484 GD patients, including 203 patients with GO were studied. CNV was detected by real-time polymerase chain reaction (PCR) using TaqMan™ probes and the relative copy number (CN) was estimated by using the comparative Ct method.

Results

The differences in the distribution of TSHR CNV in healthy controls and GD patients were statistically significant (p value = 0.01). However, the difference in the distribution of TSHR CNV in the control group and the GO group was not statistically significant (p value = 0.06). For TLR7 CNV, the results were not significantly different when we compared the distribution in healthy controls and GD patients and in healthy controls and GO patients (p values for Fisher’s exact test were 0.13 and 0.09, respectively). However, a lower than normal CNV for TLR7 (CNV < 2 for female and CNV < 1 for male) was found to have a protective effect against the development of GD (odds ratio (OR) = 0.24; 95% confidence interval (CI), 0.07-0.75) after adjusting for age and gender.

Conclusions

These results suggested that TSHR and TLR7 CNV might be associated with susceptibility to GD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lin CH, Lin YC, Wu JY, Pan WH, Chen YT, Fann CS: A genome-wide survey of copy number variations in Han Chinese residing in Taiwan. Genomics. 2009, 94 (4): 241-246. 10.1016/j.ygeno.2009.06.004.CrossRefPubMed Lin CH, Lin YC, Wu JY, Pan WH, Chen YT, Fann CS: A genome-wide survey of copy number variations in Han Chinese residing in Taiwan. Genomics. 2009, 94 (4): 241-246. 10.1016/j.ygeno.2009.06.004.CrossRefPubMed
2.
go back to reference Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al: Global variation in copy number in the human genome. Nature. 2006, 444 (7118): 444-454. 10.1038/nature05329.CrossRefPubMedPubMedCentral Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al: Global variation in copy number in the human genome. Nature. 2006, 444 (7118): 444-454. 10.1038/nature05329.CrossRefPubMedPubMedCentral
3.
go back to reference Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009, 459 (7246): 569-573. 10.1038/nature07953.CrossRefPubMedPubMedCentral Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, et al: Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009, 459 (7246): 569-573. 10.1038/nature07953.CrossRefPubMedPubMedCentral
4.
go back to reference Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, et al: Strong association of de novo copy number mutations with autism. Science. 2007, 316 (5823): 445-449. 10.1126/science.1138659.CrossRefPubMedPubMedCentral Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, et al: Strong association of de novo copy number mutations with autism. Science. 2007, 316 (5823): 445-449. 10.1126/science.1138659.CrossRefPubMedPubMedCentral
5.
go back to reference Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008, 320 (5875): 539-543. 10.1126/science.1155174.CrossRefPubMed Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008, 320 (5875): 539-543. 10.1126/science.1155174.CrossRefPubMed
6.
go back to reference Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mosse YP, Wood A, Lynch JE, et al: Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009, 459 (7249): 987-991. 10.1038/nature08035.CrossRefPubMedPubMedCentral Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mosse YP, Wood A, Lynch JE, et al: Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009, 459 (7249): 987-991. 10.1038/nature08035.CrossRefPubMedPubMedCentral
7.
go back to reference Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Wiklund F, Wiley K, Isaacs SD, Stattin P, et al: Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res. 2009, 69 (6): 2176-2179. 10.1158/0008-5472.CAN-08-3151.CrossRefPubMedPubMedCentral Liu W, Sun J, Li G, Zhu Y, Zhang S, Kim ST, Wiklund F, Wiley K, Isaacs SD, Stattin P, et al: Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer. Cancer Res. 2009, 69 (6): 2176-2179. 10.1158/0008-5472.CAN-08-3151.CrossRefPubMedPubMedCentral
8.
go back to reference Shlien A, Malkin D: Copy number variations and cancer susceptibility. Curr Opin Oncol. 2010, 22 (1): 55-63. 10.1097/CCO.0b013e328333dca4.CrossRefPubMed Shlien A, Malkin D: Copy number variations and cancer susceptibility. Curr Opin Oncol. 2010, 22 (1): 55-63. 10.1097/CCO.0b013e328333dca4.CrossRefPubMed
9.
go back to reference Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, de Smith A, Blakemore AI, et al: FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007, 39 (6): 721-723. 10.1038/ng2046.CrossRefPubMedPubMedCentral Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, de Smith A, Blakemore AI, et al: FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007, 39 (6): 721-723. 10.1038/ng2046.CrossRefPubMedPubMedCentral
10.
go back to reference Kelley J, Johnson MR, Alarcon GS, Kimberly RP, Edberg JC: Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum. 2007, 56 (10): 3375-3378. 10.1002/art.22916.CrossRefPubMed Kelley J, Johnson MR, Alarcon GS, Kimberly RP, Edberg JC: Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum. 2007, 56 (10): 3375-3378. 10.1002/art.22916.CrossRefPubMed
11.
go back to reference Mamtani M, Anaya JM, He W, Ahuja SK: Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010, 11 (2): 155-160. 10.1038/gene.2009.71.CrossRefPubMed Mamtani M, Anaya JM, He W, Ahuja SK: Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010, 11 (2): 155-160. 10.1038/gene.2009.71.CrossRefPubMed
12.
go back to reference Ptacek T, Li X, Kelley JM, Edberg JC: Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res. 2008, 123 (1–4): 142-147.PubMed Ptacek T, Li X, Kelley JM, Edberg JC: Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res. 2008, 123 (1–4): 142-147.PubMed
13.
go back to reference Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, et al: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med. 2008, 205 (7): 1573-1582. 10.1084/jem.20072413.CrossRefPubMedPubMedCentral Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, et al: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med. 2008, 205 (7): 1573-1582. 10.1084/jem.20072413.CrossRefPubMedPubMedCentral
14.
go back to reference Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, et al: Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves’ disease. Hum Mol Genet. 2009, 18 (9): 1704-1713. 10.1093/hmg/ddp087.CrossRefPubMed Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, et al: Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves’ disease. Hum Mol Genet. 2009, 18 (9): 1704-1713. 10.1093/hmg/ddp087.CrossRefPubMed
15.
go back to reference Brand OJ, Gough SC: Genetics of thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol. 2010, 322 (1–2): 135-143.CrossRefPubMed Brand OJ, Gough SC: Genetics of thyroid autoimmunity and the role of the TSHR. Mol Cell Endocrinol. 2010, 322 (1–2): 135-143.CrossRefPubMed
16.
go back to reference Yin X, Latif R, Bahn R, Tomer Y, Davies TF: Influence of the TSH receptor gene on susceptibility to Graves’ disease and Graves’ ophthalmopathy. Thyroid. 2008, 18 (11): 1201-1206. 10.1089/thy.2008.0098.CrossRefPubMedPubMedCentral Yin X, Latif R, Bahn R, Tomer Y, Davies TF: Influence of the TSH receptor gene on susceptibility to Graves’ disease and Graves’ ophthalmopathy. Thyroid. 2008, 18 (11): 1201-1206. 10.1089/thy.2008.0098.CrossRefPubMedPubMedCentral
17.
go back to reference Gianoukakis AG, Khadavi N, Smith TJ: Cytokines, Graves’ disease, and thyroid-associated ophthalmopathy. Thyroid. 2008, 18 (9): 953-958. 10.1089/thy.2007.0405.CrossRefPubMedPubMedCentral Gianoukakis AG, Khadavi N, Smith TJ: Cytokines, Graves’ disease, and thyroid-associated ophthalmopathy. Thyroid. 2008, 18 (9): 953-958. 10.1089/thy.2007.0405.CrossRefPubMedPubMedCentral
18.
20.
21.
go back to reference Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA: Genetic susceptibility to Graves’ ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye (Lond). 2010, 24 (6): 1058-1063. 10.1038/eye.2009.244.CrossRef Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA: Genetic susceptibility to Graves’ ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye (Lond). 2010, 24 (6): 1058-1063. 10.1038/eye.2009.244.CrossRef
23.
go back to reference Drexler SK, Foxwell BM: The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010, 42 (4): 506-518. 10.1016/j.biocel.2009.10.009.CrossRefPubMed Drexler SK, Foxwell BM: The role of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol. 2010, 42 (4): 506-518. 10.1016/j.biocel.2009.10.009.CrossRefPubMed
24.
go back to reference Caturegli P, Kimura H, Rocchi R, Rose NR: Autoimmune thyroid diseases. Curr Opin Rheumatol. 2007, 19 (1): 44-48. 10.1097/BOR.0b013e3280113d1a.CrossRefPubMed Caturegli P, Kimura H, Rocchi R, Rose NR: Autoimmune thyroid diseases. Curr Opin Rheumatol. 2007, 19 (1): 44-48. 10.1097/BOR.0b013e3280113d1a.CrossRefPubMed
25.
go back to reference Werner SC: Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977, 44 (1): 203-204. 10.1210/jcem-44-1-203.CrossRefPubMed Werner SC: Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977, 44 (1): 203-204. 10.1210/jcem-44-1-203.CrossRefPubMed
26.
go back to reference Mayo P, Hartshorne T, Li K, McMunn-Gibson C, Spencer K, Schnetz-Boutaud N: CNV analysis using TaqMan copy number assays. Curr Protoc Hum Genet. 2010, Chapter 2 (Unit2): 13-PubMed Mayo P, Hartshorne T, Li K, McMunn-Gibson C, Spencer K, Schnetz-Boutaud N: CNV analysis using TaqMan copy number assays. Curr Protoc Hum Genet. 2010, Chapter 2 (Unit2): 13-PubMed
27.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed
28.
go back to reference Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ: Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease. Clin Endocrinol (Oxf). 2010, 72 (2): 248-255. 10.1111/j.1365-2265.2009.03617.x.CrossRef Gu LQ, Zhu W, Zhao SX, Zhao L, Zhang MJ, Cui B, Song HD, Ning G, Zhao YJ: Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves’ disease. Clin Endocrinol (Oxf). 2010, 72 (2): 248-255. 10.1111/j.1365-2265.2009.03617.x.CrossRef
29.
go back to reference Ploski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, et al: Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves’ disease in three European Caucasian cohorts. PLoS One. 2010, 5 (11): e15512-10.1371/journal.pone.0015512.CrossRefPubMedPubMedCentral Ploski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, et al: Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves’ disease in three European Caucasian cohorts. PLoS One. 2010, 5 (11): e15512-10.1371/journal.pone.0015512.CrossRefPubMedPubMedCentral
30.
go back to reference Berghofer B, Haley G, Frommer T, Bein G, Hackstein H: Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production. J Immunol. 2007, 178 (7): 4072-4079.CrossRefPubMed Berghofer B, Haley G, Frommer T, Bein G, Hackstein H: Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production. J Immunol. 2007, 178 (7): 4072-4079.CrossRefPubMed
31.
go back to reference Guiducci C, Coffman RL, Barrat FJ: Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J Intern Med. 2009, 265 (1): 43-57. 10.1111/j.1365-2796.2008.02050.x.CrossRefPubMed Guiducci C, Coffman RL, Barrat FJ: Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications. J Intern Med. 2009, 265 (1): 43-57. 10.1111/j.1365-2796.2008.02050.x.CrossRefPubMed
32.
go back to reference Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006, 312 (5780): 1669-1672. 10.1126/science.1124978.CrossRefPubMed Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006, 312 (5780): 1669-1672. 10.1126/science.1124978.CrossRefPubMed
33.
go back to reference Garcia-Ortiz H, Velazquez-Cruz R, Espinosa-Rosales F, Jimenez-Morales S, Baca V, Orozco L: Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis. 2010, 69 (10): 1861-1865. 10.1136/ard.2009.124313.CrossRefPubMed Garcia-Ortiz H, Velazquez-Cruz R, Espinosa-Rosales F, Jimenez-Morales S, Baca V, Orozco L: Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis. 2010, 69 (10): 1861-1865. 10.1136/ard.2009.124313.CrossRefPubMed
34.
go back to reference Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, Lazarus JH, Pearce SH, Vaidya B, Gough SC, et al: Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab. 2006, 91 (12): 4873-4880. 10.1210/jc.2006-1402.CrossRefPubMed Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, Lazarus JH, Pearce SH, Vaidya B, Gough SC, et al: Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab. 2006, 91 (12): 4873-4880. 10.1210/jc.2006-1402.CrossRefPubMed
35.
go back to reference Kuang M, Wang S, Wu M, Ning G, Yao Z, Li L: Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves’ disease. Mol Cell Endocrinol. 2010, 319 (1–2): 23-29.CrossRefPubMed Kuang M, Wang S, Wu M, Ning G, Yao Z, Li L: Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves’ disease. Mol Cell Endocrinol. 2010, 319 (1–2): 23-29.CrossRefPubMed
Metadata
Title
Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan
Authors
Wen-Ling Liao
Lei Wan
Tzu-Yuan Wang
Ching-Chu Chen
Siu-San Tse
Chieh-Hsiang Lu
Fuu-Jen Tsai
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2014
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-14-15

Other articles of this Issue 1/2014

BMC Ophthalmology 1/2014 Go to the issue